DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 32 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,903 | -40.3% | 66,629 | 0.0% | 0.00% | – |
| Q2 2023 | $287,837 | +182.4% | 66,629 | 0.0% | 0.00% | – |
| Q1 2023 | $101,942 | -51.6% | 66,629 | -50.0% | 0.00% | – |
| Q4 2022 | $210,548 | +153.7% | 133,258 | +100.0% | 0.00% | – |
| Q3 2022 | $83,000 | -38.5% | 66,629 | 0.0% | 0.00% | – |
| Q2 2022 | $135,000 | -19.2% | 66,629 | 0.0% | 0.00% | – |
| Q1 2022 | $167,000 | -25.1% | 66,629 | +11.6% | 0.00% | – |
| Q4 2021 | $223,000 | +40.3% | 59,717 | +50.4% | 0.00% | – |
| Q3 2021 | $159,000 | +18.7% | 39,717 | +31.4% | 0.00% | – |
| Q2 2021 | $134,000 | – | 30,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Manatuck Hill Partners, LLC | 267,300 | $1,326,000 | 0.62% |
| Worth Venture Partners, LLC | 132,514 | $657,000 | 0.36% |
| WEXFORD CAPITAL LP | 400,000 | $1,984,000 | 0.23% |
| Eidelman Virant Capital | 35,000 | $173,000 | 0.09% |
| Granite Point Capital Management, L.P. | 229,970 | $1,141,000 | 0.08% |
| Patriot Financial Group Insurance Agency, LLC | 2,000 | $10,000 | 0.00% |
| GABLES CAPITAL MANAGEMENT INC. | 125 | $1,000 | 0.00% |
| FNY Investment Advisers, LLC | 521 | $2,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 99,340 | $493,000 | 0.00% |
| TORONTO DOMINION BANK | 48 | $0 | 0.00% |